Carregant...
New emerging targets in cancer immunotherapy: the role of neoantigens
The success of cancer therapies with immune checkpoint inhibitors is transforming the treatment of patients with cancer and fostering cancer research. Therapies that target immune checkpoint inhibitors have shown unprecedented rates of durable long-lasting responses in patients with various cancer t...
Guardat en:
| Publicat a: | ESMO Open |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7326255/ https://ncbi.nlm.nih.gov/pubmed/32269031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2020-000684 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|